Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisIf approved, tolebrutinib would be ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

PARIS, France I March 25, 2025 I The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to ...

US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis: Paris Wednesday, March 26, 2025, 09:00 Hrs [IST] The US F ...

Sanofi’s tolebrutinib has been accepted for priority review by the US Food and Drug Administration (FDA) to treat certain ...

Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish multiple sclerosis from migraine pathology. Medscape Medical News ...

Most of us rely heavily on shipping services like FedEx or UPS to ensure we receive the correct packages. If that system was ...

This article delves into the theoretical roles of these peptides in brain research and discusses the directions in which they ...

Dysfunctional Family. A family tree of tau folds now incorporates two new structures—P301L, P301T (bottom)—and fills in ...

FibroBiologics and Charles River have announced the completion of FibroBiologics’ master cell bank for a product that will be evaluated for the treatment of diabetic foot ulcers and other chronic ...

Neuroplasticity Enhancement Devices Market The growing existence of Alzheimer's and Parkinson's disease globally is driving the market dema ...